Ethyl 2-(2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)acetate

Catalog No. :
ACFZAO168
CAS No. :
312904-87-3
Molecular Formula :
C8H10N2O4
Molecular Weight :
198.18

IUPAC Name:ethyl 2-(2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)acetate

Ethyl 2-(2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$83.00Login to see priceIn stockInquiry
250mg95%$150.00Login to see priceIn stockInquiry
1g95%$299.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)acetate
IUPAC Nameethyl 2-(2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)acetate
MDL No.MFCD08275059 | MFCD10574968
Molecular FormulaC8H10N2O4
Molecular Weight198.18
SMILESCCOC(=O)CN1C=CNC(=O)C1=O
InChI KeyYQIWYZDBGDASKD-UHFFFAOYSA-N
SynonymETHYL 2-(3-HYDROXY-2-OXOPYRAZIN-1(2H)-YL)ACETATE;(3-Hydroxy-2-oxo-2H-pyrazin-1-yl)-acetic acid ethyl ester;Ethyl 2-(2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)acetate;1(2H)-Pyrazineacetic acid, 3,4-dihydro-2,3-dioxo-, ethyl ester;ethyl (2,3-dioxo-3,4-dihydropyrazin-1(2H)-yl)acetate
CAS No.312904-87-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFZAO168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFZAO168 route product structure diagram
    ACFZAO168312904-87-3 In Stock
Inquiry

2. ACFZAO168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFZAO168 route product structure diagram
    ACFZAO168312904-87-3 In Stock
Inquiry

Comments (0)